Federal Bank, SBI Cards, HCG & Narayana Hrudayalaya: 4 stock picks by SMC Global
SMC Global, citing the management, said that Federal Bank has reported strong broad based credit growth in Q1FY25, along with the overall costs been well managed.
- Sep 9, 2024,
- Updated Sep 9, 2024 1:23 PM IST
As the rising volatility continues to grip the headline indices, domestic brokerage firm SMC Global Securities has suggested four stocks- SBI Card & Payment Services Ltd, Narayana Hrudayalaya, Healthcare Global Enterprises Ltd (HCG) and Federal Bank Ltd - to bet amid the scarce opportunities to make money. The brokerage has picked the former two based on their sound technical parameters, while the latter two appear to be solid on the fundamental parameters. Here's what the brokerage has to say about these counters:
Bengaluru-based Healthcare Global Enterprises (HCG) is the largest provider of cancer care in India. Through its network of 22 comprehensive cancer centers across India and Africa, HCG has brought advanced cancer care to the doorstep of millions of people. HCG’s comprehensive cancer centers provide expertise and advanced technologies for the effective diagnosis and treatment of cancer under one roof. Under the 'Milann' brand, HCG operates 7 fertility centers. According to the management of the company, consistent revenue growth is driven by volume increases across modalities and enhanced operational performance, supported by the strong results of its established centers and the progress in its emerging centers. The company has been diligently working to turnaround operations at its emerging centers, and its Kolkata center has shown promising growth and is now contributing to its overall EBITDA. The company is confident that the emerging centers will see revenue growth and margin expansion over the next 12 months. Thus, it is expected that the stock will see a price target of Rs 448 in 8 to 10 months’ time.
As the rising volatility continues to grip the headline indices, domestic brokerage firm SMC Global Securities has suggested four stocks- SBI Card & Payment Services Ltd, Narayana Hrudayalaya, Healthcare Global Enterprises Ltd (HCG) and Federal Bank Ltd - to bet amid the scarce opportunities to make money. The brokerage has picked the former two based on their sound technical parameters, while the latter two appear to be solid on the fundamental parameters. Here's what the brokerage has to say about these counters:
Bengaluru-based Healthcare Global Enterprises (HCG) is the largest provider of cancer care in India. Through its network of 22 comprehensive cancer centers across India and Africa, HCG has brought advanced cancer care to the doorstep of millions of people. HCG’s comprehensive cancer centers provide expertise and advanced technologies for the effective diagnosis and treatment of cancer under one roof. Under the 'Milann' brand, HCG operates 7 fertility centers. According to the management of the company, consistent revenue growth is driven by volume increases across modalities and enhanced operational performance, supported by the strong results of its established centers and the progress in its emerging centers. The company has been diligently working to turnaround operations at its emerging centers, and its Kolkata center has shown promising growth and is now contributing to its overall EBITDA. The company is confident that the emerging centers will see revenue growth and margin expansion over the next 12 months. Thus, it is expected that the stock will see a price target of Rs 448 in 8 to 10 months’ time.